A 50-year-old man presented with a left axillary mass that had been palpable for the previous 2 years. He had experienced pain in the left shoulder and chest wall area for the previous 3 years. He reported his pain was 5 to 6 out of 10 on the visual analog scale. He denied any weakness, numbness, or tingling of the arm.
Case Presentation
A 50-year-old man presented with a left axillary mass that had been palpable for the previous 2 years. He had experienced pain in the left shoulder and chest wall area for the previous 3 years. He reported his pain was 5 to 6 out of 10 on the visual analog scale. He denied any weakness, numbness, or tingling of the arm.
Physical exam revealed a firm, ovoid mass on the inside of the left upper arm. The mass was slightly tender to palpation. The mass was more mobile in the horizontal direction than the vertical. The overlying skin looked normal with no discoloration or discharge. No other swellings were noted in the body. We elicited a positive Tinel sign with ulnar distribution tingling. Physical exam otherwise was unremarkable.
Magnetic resonance imaging (MRI) with and without contrast demonstrated a T1 hypointense, T2 hyperintense homogeneously enhancing mass within the left upper arm (►Fig. 1). The mass was mildly lobulated, but well circumscribed, and measured 4.2 cm craniocaudal Â 2.1 cm transverse Â 2.2 cm anteroposterior. It was located between the triceps and coracobrachialis/biceps muscles, just posterior to the neurovascular bundle of the upper extremity. It appeared that the mass was arising exophytically from the ulnar nerve, and it was presumed to be a schwannoma.
We elected to remove the mass given the patient's pain. The median, ulnar, and medial antebrachial cutaneous nerves, as well as the brachial artery, were identified during our dissection (►Fig. 2). There was no nerve that was contributing to the mass. A branch of the brachial vein, however, was seen entering the mass at the more cephalad end. This was carefully dissected and appeared to be a neck. At this point, we identified that this mass appeared to be a venous malformation (VM). Thus, the contributing vein was ligated and the VM was removed. Gross examination of a cross-section revealed blood clots. Histology confirmed a VM and demonstrated no nervous tissue (►Fig. 3).
Discussion
Venous Malformations, thin-walled vascular dilations of various sizes, are the most common type of vascular malformation. The incidence of VM is estimated to be between 1/10,000 and 1/5,000 and the prevalence is thought to be Keywords ► brachial plexus ► nerve sheath tumor ► peripheral nerve schwannoma ► venous malformation
Abstract
We present the case of a venous malformation (VM) masquerading as a schwannoma. VMs are thin-walled vascular dilations of various sizes that typically present as soft, compressible, blue masses that are associated with pain or dysesthesia. VMs are commonly found in the head and neck as well as the distal extremities. Notably, slow-flow VMs are hypointense on T1-weighted imaging, hyperintense on T2-weighted imaging, and enhance markedly with contrast. However, VMs tend to be poorly circumscribed and fraught with venous lakes and phleboliths. Conservative therapy and sclerotherapy are the primary treatment options. In this case report, we present a VM presenting near the neurovascular bundle of the upper extremity axilla. Our case is unique in that the patient presented with symptoms and imaging qualities characteristic for a peripheral nerve schwannoma. approximately 1%.
1,2 Though all are present at birth, the most rapid growth occurs during puberty, and they continue to grow throughout life; only 50% are identified at birth. 3 In this respect, they differ from hemangiomas. VMs can appear superficial, deep, diffuse, localized, or, rarely, as multiple lesions. They can occur in any tissue in the body. The most common locations reported are in the head and neck (40%), followed by the extremities (40%) and trunk (20%). 4 Patients with VMs present as soft, blue masses that are compressible; the most common complaint is pain.
Proper workup for underlying coagulopathy must follow a diagnosis of VM. Various genetic syndromes, such as Kassabach-Merritt syndrome, Servelle-Martorell syndrome, Klippel-Trénaunay syndrome, and Parkes Weber syndrome, have been associated with vascular malformations among other pathologies and must be excluded.
MRI has become the modality of choice for imaging VMs. Slow-flow VMs are typically hypointense on T1-weighted imaging, have bright signal intensity on T2, and enhance markedly with contrast.
5 Very often, large VMs have obvious phleboliths (dark circular areas) and poorly defined venous lakes on T2 imaging. Indications for treatment for VMs primarily include pain and functional impairment, or are cosmesis related. Elastic therapy, sclerotherapy, and surgical resection are the potential therapeutic options. Elastic compression stockings have been shown to limit the swelling and improve coagulopathy. 6 In fact, in one series of 121 successfully treated VMs, 8% had no treatment and 24% had aspirin and compression garments. VMs localized to single muscle or muscle group or causing neurologic impairment. In the Enjolras et al series, 6 of 11 upper extremity VMs were treated with surgical skin excision with or without muscle excision. Outcomes were reported as bad (1/6), unchanged (2/6), mediocre (1/6), and improved (2/6).
6
The focus we would like to draw in this article, however, is a comparison with peripheral nerve schwannomas (PNSs). Of note, PNSs also present with a palpable mass (96%) often associated with referred dysesthesia (95%) and similarly, on MRI sequencing, are isotense or hypointense to muscle on T1 and hyperintense on T2.
8 They also vividly enhance with contrast. Typically, intramuscular VMs can be differentiated from PNSs based on poorly circumscribed venous lakes and phleboliths. Simon et al demonstrated that high-resolution ultrasonography (HRUS) correctly differentiated tumor and motor fascicles when compared with intraoperative electrophysiologic monitoring. 9 Differentiating between PNS and VM with HRUS is difficult as blood can often be stagnant in slow-flow VMs. However, Zardi et al demonstrate the benefit of power flow sonography in identifying "red" and "blue" vascular signal spots that indicate vascularity which is present in PNSs but absent in VMs. 9 Likewise, VMs will demonstrate compressibility given even light pressure from a US scanner head, whereas PNS are not compressible with scanner head pressure. MRI with tractography demonstrated good correspondence with both HRUS and intraoperative electrophysiologic monitoring. 10 This may be useful for differentiating PNS and VM. Primary treatment for a PNS is complete surgical resection, whereas that for a VM is conservative therapy with or without sclerotherapy.
11 As peripheral nerve surgeons who have limited exposure to peripheral vascular anomalies, we must be wary of a slow-flowing VM in our differential for an upper extremity schwannoma. We recommend being cognizant to the physical exam and minute details in MRI, differences of which are demonstrated in ►Table 1. Alternatively, a trial of conservative compressive therapy with aspirin for a few weeks for suspicious masses may elucidate this differential. However, we do not recommend this approach as aspirin may postpone surgery and, more importantly, painful, peripheral masses could very well be a malignant peripheral nerve sheath tumor, which mandate early resection.
